Shanghai Shyndec Pharmaceutical Co (SHSE:600420) 5-Year EBITDA Growth Rate : -4.20% (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Shanghai Shyndec Pharmaceutical Co 5-Year EBITDA Growth Rate?

Shanghai Shyndec Pharmaceutical Co's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.28.

During the past 12 months, Shanghai Shyndec Pharmaceutical Co's average EBITDA Per Share Growth Rate was 26.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -1.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -4.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shanghai Shyndec Pharmaceutical Co was 57.80% per year. The lowest was -8.60% per year. And the median was 10.80% per year.

Competitive Comparison of Shanghai Shyndec Pharmaceutical Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Shyndec Pharmaceutical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Shyndec Pharmaceutical Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Shyndec Pharmaceutical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Shyndec Pharmaceutical Co's 5-Year EBITDA Growth Rate falls into.

Shanghai Shyndec Pharmaceutical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Shanghai Shyndec Pharmaceutical Co (SHSE:600420) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Shanghai Shyndec Pharmaceutical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Shyndec Pharmaceutical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Shyndec Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shyndec Pharmaceutical Co Ltd (SHSE:600420) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No.1320 Beijinxi Road, Shanghai, CHN, 200040

Website

http://www.shyndec.com

Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.

Executives

Li Hao	senior management
Ni Feng	Director
Li Xian Lin	senior management
Hao Chao Feng	senior management
Lian Wan Yong	Director
Han Yan Lin	Director
Yang Wen Ming	Supervisors
Feng Ming	Director

Shanghai Shyndec Pharmaceutical Co Headlines

No Headlines